Diego S.
About Diego S.
Diego S. serves as the General Manager for the Intercontinental Region at Kite, a Gilead Company, and has extensive experience in the pharmaceutical industry, particularly in oncology and business development.
Work at Kite Pharma
Diego S. serves as the General Manager for the Intercontinental Region at Kite, a Gilead Company. He has held this position since 2021 and is based in São Paulo, Brazil. In his role, he oversees operations and strategic initiatives within the region, leveraging his extensive experience in the pharmaceutical industry.
Previous Experience in Pharmaceuticals
Prior to his current role at Kite Pharma, Diego S. held several key positions in the pharmaceutical sector. He worked at Sandoz as the Marketing and Business Development Director from 2014 to 2015. He also served as the Oncology and Rare Diseases Business Franchise Head at Novartis Oncology from 2017 to 2021. His earlier roles at Sandoz included Regional Portfolio Director for LatAm and Strategic Planning and Portfolio Management Director.
Education and Expertise
Diego S. has a strong educational background in pharmaceutical technology. He earned a Master of Science degree from the University of São Paulo, where he focused on emulsified systems, topical products, and drug development from 2003 to 2005. He also holds a degree in Pharmacy from Universidade de Mogi das Cruzes, where he studied pharmaceutical technology, pharmacology, and cosmetic development from 1997 to 2000.
Skills in Pharmaceutical Technology
Diego S. possesses specialized skills in developing emulsified systems and topical products, which are integral to his expertise in pharmaceutical technology. His knowledge extends to P&L management and business development, which supports his strategic decision-making in the pharmaceutical industry.
Background in Marketing and Oncology
Diego S. has a robust background in marketing and oncology, which enhances his effectiveness as a General Manager. His experience in various leadership roles within the pharmaceutical sector has equipped him with the necessary skills to drive business growth and innovation in oncology and rare diseases.